Journal of Clinical Microbiology, May 1999, p. 1313-1318, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Characterization of a New Ribotype of
Vibrio cholerae O139 Bengal Associated with an Outbreak
of Cholera in Bangladesh
Shah M.
Faruque,1,*
A. K.
Siddique,2
Manujendra N.
Saha,1
Asadulghani,1
M. Mostafizur
Rahman,1
K.
Zaman,2
M. John
Albert,1
David A.
Sack,3 and
R. Bradley
Sack3
Molecular Genetics Laboratory, Laboratory
Sciences Division,1 and Epidemic Control
Preparedness Program, Health and Population Extension
Division,2 International Centre for Diarrhoeal
Disease Research, Bangladesh, Dhaka-1212, Bangladesh, and
Department of International Health, Johns Hopkins University,
Baltimore, Maryland3
Received 9 November 1998/Returned for modification 30 December
1998/Accepted 12 February 1999
 |
ABSTRACT |
Vibrio cholerae O139 Bengal initially appeared in the
southern coastal region of Bangladesh and spread northward, causing explosive epidemics during 1992 and 1993. The resurgence of V. cholerae O139 during 1995 after its transient displacement by a
new clone of El Tor vibrios demonstrated rapid changes in the epidemiology of cholera in Bangladesh. A recent outbreak of cholera in
two north-central districts of Bangladesh caused by V. cholerae O139 led us to analyze strains collected from the
outbreak and compare them with V. cholerae O139 strains
isolated from other regions of Bangladesh and neighboring India to
investigate their origins. Analysis of restriction fragment length
polymorphisms in genes for conserved rRNA (ribotype) revealed that the
recently isolated V. cholerae O139 strains belonged to a
new ribotype which was distinct from previously described ribotypes of
toxigenic V. cholerae O139. All strains carried the genes
for toxin-coregulated pili (tcpA and tcpI) and
accessory colonization factor (acfB), the regulatory gene
toxR, and multiple copies of the lysogenic phage genome
encoding cholera toxin (CTX
) and belonged to a previously described
ctxA genotype. Comparative analysis of the rfb
gene cluster by PCR revealed the absence of a large region of the
O1-specific rfb operon downstream of the rfaD
gene and the presence of an O139-specific genomic region in all O139
strains. Southern hybridization analysis of the O139-specific genomic
region also produced identical restriction patterns in strains
belonging to the new ribotype and those of previously described
ribotypes. These results suggested that the new ribotype of Bengal
vibrios possibly originated from an existing strain of V. cholerae O139 by genetic changes in the rRNA operons. In contrast
to previously isolated O139 strains which mostly had resistance to
trimethoprim, sulfamethoxazole, and streptomycin encoded by a
transposon (SXT element), 68.6% of the toxigenic strains analyzed in
the present study, including all strains belonging to the new ribotype,
were susceptible to these antibiotics. Molecular analysis of the SXT
element revealed possible deletion of a 3.6-kb region of the SXT
element in strains which were susceptible to the antibiotics. Thus,
V. cholerae O139 strains in Bangladesh are also undergoing
considerable reassortments in genetic elements encoding antimicrobial resistance.
 |
INTRODUCTION |
Vibrio cholerae O139
Bengal emerged as a second etiologic agent of cholera in 1992 and
caused explosive epidemics throughout Bangladesh, India, and
neighboring countries (4, 25, 26). In Bangladesh, this new
serogroup of epidemic V. cholerae was first detected in the
southern coastal districts and offshore islands (29). The
spread of the epidemic initially remained largely confined to the
coastal districts, where the aquatic environment is saline and typical
of the Bay of Bengal. Subsequently, V. cholerae O139 spread
to the northeastern and north-central regions of the country and caused
outbreaks of cholera (29). However, during 1994 and until
the middle of 1995, in most northern and central areas of Bangladesh,
including the capital city Dhaka, the O139 vibrios were replaced by a
new clone of V. cholerae O1 of the El Tor biotype, whereas
in the southern coastal regions V. cholerae O139 continued
to exist (7, 9, 29). During the second half of 1995 and in
1996, nearly 4 years after the initial detection of O139 vibrios, cases
due to both V. cholerae O1 and V. cholerae O139
were detected in various regions of Bangladesh. Analysis of these
isolates revealed the emergence of a new clone of V. cholerae O139, and epidemiological assessment suggested that the new clone probably originated in the northern region of the country and
spread toward the south (9). Recent surveillance by the Epidemic Control Preparedness Program of the International Centre for
Diarrhoeal Disease Research, Bangladesh (ICDDR,B), during November 1997 revealed an outbreak of cholera due to V. cholerae O139 in
Mymensingh and Kishoreganj, two rural districts of Bangladesh situated
north of Dhaka. A preliminary estimate revealed that over 50,000 cases
of cholera and at least 34 deaths occurred during this outbreak
(28a). Details of the surveillance will be published elsewhere. In the present study, we used molecular techniques to
characterize V. cholerae O139 strains isolated from the
recent outbreak and compared these with V. cholerae O139
strains isolated from other parts of Bangladesh and neighboring
countries between 1995 and 1998 to study clonal relationships and
understand the origins of these recently emerged epidemic strains.
 |
MATERIALS AND METHODS |
V. cholerae strains.
A total of 68 clinical
isolates of V. cholerae O139 were included in this study.
Strains isolated in Bangladesh consisted of 19 isolates from the
cholera outbreak in 1997 in two north-central districts of Bangladesh
and 39 strains isolated in other regions of Bangladesh between 1995 and
1998. Other strains consisted of six strains isolated in India in 1997 (courtesy of G. B. Nair, National Institute of Cholera and Enteric
Diseases, Calcutta), three strains isolated in Thailand (Armed Forces
Research Institute of Medical Sciences, Bangkok), and a single
nontoxigenic strain isolated in Argentina in 1993. Strains were stored
either in a lyophilized form or in sealed deep nutrient agar at room
temperature at the culture collection of the ICDDR,B. Before use, the
identities of the cultures were confirmed by biochemical reaction and
serology (36). Details of the strains are presented in Table
1.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Analysis of genes for rRNA, CT (ctxA), and the
SXT element in clinical strains of toxigenic V. cholerae
O139 isolated between 1995 and 1998a
|
|
Probes and hybridization.
Colony blots were prepared with
nylon filters (Hybond; Amersham International PLC, Ayelesbury, United
Kingdom) and processed by a standard method (16). Briefly,
colonies were lysed with denaturing solution (0.5 M NaOH, 1.5 M NaCl)
and neutralized in neutralizing solution (0.5 M Tris-HCl [pH 8.0],
1.5 M NaCl), and the liberated DNA was fixed to the nylon membrane by
exposure to UV light for 3 min in accordance with the supplier's
instructions. For preparation of DNA blots, total cellular DNA was
isolated from overnight cultures as described previously
(32). Five-microgram aliquots of DNA were digested with the
appropriate restriction enzymes (Bethesda Research Laboratories
[BRL], Gaithersburg, Md.), electrophoresed in 0.8% agarose gels, and
blotted onto nylon membranes (Hybond; Amersham) by Southern blotting
(30).
The gene probe used in this study to detect the CTX genetic element was
a 0.5-kb EcoRI fragment of pCVD27 (12) containing part of the ctxA gene. The toxR gene probe was a
2.4-kb BamHI fragment of pVM7 (18). The rRNA gene
probe consisted of a 7.5-kb BamHI fragment of the
Escherichia coli rRNA clone pKK3535 (3, 32). The
O139-specific DNA probe was a 1.3-kb EcoRI fragment of
pCRII-A3 (21), and the SXT probe was a NotI
fragment of pSXT1 (35). The probes were labeled by random
priming (11) with a random primer DNA labeling kit (BRL) and
[
-32P]dCTP (3,000 Ci/mmol) (Amersham). Southern blots
and colony blots were hybridized with the labeled probes, and
autoradiographs were developed as described by us previously
(7-9).
PCR assays.
Presence of the toxin-coregulated pilus (TCP)
pathogenicity island was determined by PCR assays specific for the
tcpA, tcpI, and acfB genes. All
oligonucleotides used either as probes or PCR primers were synthesized
commercially by Oswel DNA Service (University of Edinburgh, Edinburgh,
United Kingdom), and PCR reagents and kits were purchased from
Perkin-Elmer Corporation (Norwalk, Conn.). Presence of tcpA
genes specific for the classical and El Tor biotypes was determined by
a multiplex PCR assay (14). The tcpI gene was
detected by a specific PCR assay described by us previously
(7). The acfB gene was detected by a PCR assay based on the published sequence of acfB (6) with
two primers having the following sequences:
5'GGACCAAGCATTATTATCTCT and 5'AATGATAAACTTACTGATTAA. The PCR assay amplified a 1.9-kb region of the acfB
gene. Amplification was performed for 25 cycles consisting of
denaturation at 94°C for 2 min, annealing of primers at 50°C for 2 min, and primer extension at 72°C for 3 min.
PCR assays for defined regions of the rfb gene cluster and
adjoining sequences were performed with six different sets of primers derived from the sequence of the V. cholerae O1
rfb gene cluster, as described by us previously
(9). The expected sizes of the amplicons were ascertained by
electrophoresis in agarose gels, and the identity of each PCR product
was also verified by Southern blot hybridization. PCR-negative strains
were further confirmed for the absence of the relevant genes by colony
blot hybridization with the corresponding PCR-generated amplicons from
a positive control strain, 569B, as specific probes.
Antimicrobial resistance.
All V. cholerae
isolates were tested for antimicrobial resistance by the method of
Bauer et al. (2) with standard antibiotic disks (Oxoid Ltd.,
Basingstoke, Hampshire, United Kingdom) at the following antibiotic
concentrations (in micrograms per disk): ampicillin, 10;
chloramphenicol, 30; streptomycin, 10; tetracycline, 30;
trimethoprim-sulfamethoxazole (SXT), 1.25 and 23.75, respectively; kanamycin, 30; gentamicin, 10; ciprofloxacin, 5; norfloxacin, 10;
nalidixic acid, 30.
 |
RESULTS AND DISCUSSION |
The epidemiology of cholera in the flood plains of the northern
region of Bangladesh had previously been shown to differ considerably from that in the southern coastal region (29), probably due to differences in the water ecologies between the two regions. Soon
after the emergence of V. cholerae O139, the existing
strains of V. cholerae O1 were almost completely displaced
and the O139 vibrios continued to dominate until the emergence of a new
clone of El Tor vibrios (7). The new clone of El Tor vibrios
displaced the O139 vibrios during 1994 and 1995 in the central and
northern areas of Bangladesh, but the O139 vibrios continued to exist
and became endemic in the southern coastal region, where this serogroup was initially detected in 1993 (4, 29). During 1995 and
1996, after the reemergence of V. cholerae O139, molecular
epidemiological studies suggested that strains isolated from the
southern regions were remnants of the initial clones whereas those
isolated in the northern districts belonged to a new clone
(9). The present study was designed to ascertain whether
strains isolated from the recent outbreak in the two north-central
districts of Bangladesh also represented a new clone of V. cholerae O139.
Ribotype analysis.
We have previously examined restriction
patterns of conserved rRNA genes (ribotypes) and cholera toxin genes or
chromosomal DNA flanking these genes to differentiate among clones of
toxigenic V. cholerae which were otherwise phenotypically
identical (7-9). These studies have also shown that
BglI was the most discriminatory restriction enzyme used for
ribotyping. In the present study, analysis of rRNA genes with
BglI revealed three different restriction patterns (patterns
I through III) among the toxigenic strains (Fig.
1). The nontoxigenic O139 strain from
Argentina produced a restriction pattern which was widely different
from those of the toxigenic strains described by us previously
(9). All of the 19 strains isolated from the recent outbreak
produced restriction pattern III (Fig. 1), which was different from the
previously reported ribotype patterns of V. cholerae
isolates belonging to the O139 or O1 serogroup (7-9, 23,
24). Strains isolated in India and Thailand analyzed in the
present study produced either restriction pattern I or II (Table 1).
Thus, V. cholerae O139 strains isolated from the recent
epidemic in the north-central region of Bangladesh belonged to a new
ribotype. The rRNA gene restriction patterns were reproducible in
repeated assays and consisted of seven to eight major bands of between
12.5 and 3.9 kb in size. The restriction pattern representing the new
ribotype contained a unique band of 12.5 kb which was not present in
any of the other restriction patterns (Fig. 1). Hence, the O139 strains isolated from the recent epidemic were distinguishable from previously described O139 vibrios based on the ribotype pattern. The other two
patterns detected among toxigenic O139 strains in the present study
(patterns I and II) have been described previously (9), and
these strains are likely to be remnants of the original clones of
V. cholerae O139 which emerged during 1992 and 1993. However, another clone of toxigenic V. cholerae
(9) which appeared transiently in 1996 was not found among
the isolates analyzed in the present study. The detection of strains
belonging to a new ribotype in the present study suggested that
V. cholerae O139 strains are undergoing genetic changes
leading to increased ribotype diversity. At present there is no
standardized systematic nomenclature for designating ribotypes of
V. cholerae O139 Bengal; hence, strains belonging to similar
ribotypes have been designated differently in previous reports (8,
9, 24). With the prospect of emerging ribotype diversity among
V. cholerae O139 isolates, it is important to establish a
systematic nomenclature for identifying and monitoring the emergence
and spread of epidemic O139 strains. We propose that the V. cholerae O139 Bengal strains producing the three different ribotype patterns, I through III (Fig. 1), be designated ribotypes B-I,
B-II, and B-III (Table 1). Since previous studies have suggested that
the nontoxigenic non-Bengal O139 strain (9) isolated in Argentina has an origin widely different from the epidemic Bengal strains, we propose the ribotype designation NB-1 for this strain. Analysis of a large number of V. cholerae O139 strains
isolated in different countries is being carried out in our laboratory to further develop a standardized system for ribotype designations of
toxigenic V. cholerae.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 1.
Southern hybridization analysis of rRNA genes in
V. cholerae O139 strains isolated between 1995 and 1998 in
Bangladesh, India, and Thailand. Genomic DNA was digested with
BglI and probed with a 7.5-kb BamHI fragment of
the E. coli rRNA clone pKK3535. Restriction pattern I,
produced by two strains belonging to designated ribotype B-I isolated
from Bangladesh and Thailand, respectively, are shown in lanes 1 and 2;
restriction pattern II, produced by three strains belonging to ribotype
B-II isolated in Bangladesh, India, and Thailand, respectively, are
shown in lanes 3 through 5; and lanes 6 through 8 show restriction
pattern III, produced by the new ribotype of V. cholerae
O139 designated B-III, isolated from a recent outbreak in two
north-central districts of Bangladesh. The pattern produced by the
nontoxigenic O139 strain isolated in Argentina is shown in lane 9. Numbers indicating molecular sizes of bands correspond to a 1-kb DNA
ladder (BRL) used as a molecular size marker.
|
|
Analysis of virulence genes.
Previous studies have
demonstrated that the rRNA gene restriction patterns (ribotypes) could
be considered fairly stable markers for identifying different clones,
and generally different ribotypes have also shown differences in the
restriction patterns of several other genes studied (7, 9).
We subjected the strains belonging to the new ribotype to further
analysis to determine whether major pathogenic genes carried by strains
of the new ribotype showed genetic dissimilarities with strains of the
other ribotypes studied. The major colonization factor of toxigenic
V. cholerae is TCP, the expression of which is under genetic
control of the transcriptional activator ToxR and is coregulated with
the expression of cholera toxin (CT) (18, 33). Although the
major subunit of TCP is encoded by the tcpA gene, the
formation and function of the pilus assembly requires the products of a
number of other genes located on a large DNA region referred to as the
TCP pathogenicity island, which includes the tcp and
acf gene clusters (13, 15). Analysis of genes for
the TCP pathogenicity island with PCR assays for the tcpA,
tcpI, and acfB genes showed that all strains
carried the TCP pathogenicity island. The PCR assay for tcpA
amplified a 0.47-kb portion of the tcpA gene in all strains.
The PCR assays for the tcpI and acfB genes
produced amplicons of 2.1 and 1.9 kb, respectively, from all strains
tested. Colony blot hybridization revealed that all strains in the
present study also carried the toxR gene. Like previously
described O139 Bengal vibrios, the tcpA amplicon derived
from strains belonging to the new ribotype of V. cholerae
O139 was identical to that produced by El Tor strains of V. cholerae (9). The ctxAB operon, which
encodes the A and B subunits of CT, is part of a larger genetic element
originally termed the CTX genetic element (22). Recent
studies have shown that the CTX genetic element corresponds to the
genome of CTX
, a lysogenic filamentous bacteriophage
(34). In the present study, restriction fragment length
polymorphism analysis of the ctxA gene and its flanking
chromosomal sequence with the enzyme BglI revealed two
different restriction patterns (A and B) for O139 strains. The
ctxA restriction patterns consisted of either two or three
bands between 9.1 and 6.1 kb (Fig. 2).
Since the ctxA gene is known to have no internal
BglI site (17), the number of bands represented
the approximate number of copies of the integrated CTX
genome. Both
of the ctxA restriction patterns produced by strains
analyzed in the present study have been reported previously for
V. cholerae O139 strains (9). All strains
collected from the recent outbreak produced pattern B (Fig. 2) and
carried three copies of the CTX
genome. We have previously proposed
that origination of new toxigenic strains of V. cholerae is
associated with the induction and propagation of CTX
(10). Diversification of the ctxA genotype among
different strains may be a result of integration of CTX
into
different regions of the host chromosome specified by the presence of a
17-bp attachment sequence referred to as attRS
(34). Hence the new ribotype of V. cholerae O139
carries the attRS sequence at chromosomal sites similar to
other previously described O139 vibrios. These results suggested that
unlike the non-Bengal O139 strain from Argentina, which has been shown
to have a non-O1 origin (9), the new ribotype of V. cholerae O139 is closely related other V. cholerae O139
Bengal vibrios.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 2.
Southern hybridization analysis of ctxA genes
in V. cholerae O139 strains isolated from the epidemic in
the north-central region of Bangladesh (lanes 6 through 9) in 1997 and
from other districts between 1995 and 1998 (lanes 1 through 5). Genomic
DNA was digested with BglI and probed with a 0.5-kb fragment
of the ctxA gene. Restriction patterns corresponding to
ctxA genotype A are shown in lanes 1 through 4, whereas
those representing ctxA genotype B are shown in lanes 5 through 9. Numbers indicating molecular sizes of bands correspond to a
1-kb DNA ladder (BRL) used as a molecular size marker.
|
|
Antimicrobial resistance.
The O139 serogroup of V. cholerae which emerged during 1992 and 1993 was sensitive to
tetracycline and showed a trend of increased resistance to SXT and
streptomycin. Waldor and coworkers (35) reported the
presence of a 62-kb self-transmissible transposon-like element (SXT
element) encoding resistance to sulfamethoxazole, trimethoprim, and
streptomycin in V. cholerae O139 strains isolated from this
epidemic. The SXT element could be conjugally transferred from V. cholerae O139 to V. cholerae O1 and E. coli
strains, where it integrated into recipient chromosomes in a
site-specific recA-independent manner (35). In
the present study, all strains of the new ribotype and 27 of 48 strains
(56.25%) belonging to previously reported ribotypes were found to be
sensitive to SXT and streptomycin (Table 1). All strains analyzed in
the present study were also sensitive to tetracycline, ampicillin,
chloramphenicol, gentamicin, ciprofloxacin, norfloxacin, and nalidixic
acid. In keeping with the observations in Bangladesh, comparison of
antibiotic resistance patterns between the O139 strains isolated during
1992 and 1993 and those isolated in 1996 and 1997 in India also showed
that the latter strains were susceptible to SXT, unlike the O139
strains from 1992 and 1993 (19). To identify the genetic
changes associated with the observed SXT sensitivity, we used a cloned
SXT gene probe to study restriction fragment length polymorphisms in
the SXT transposon. Two different BglI restriction patterns
(patterns 1 and 2) of the SXT element were observed among the toxigenic
O139 strains tested (Fig. 3). Strains
producing pattern 2 were sensitive to SXT and streptomycin, whereas
those producing pattern 1 were resistant to all three antibiotics.
Further analysis of the restriction patterns suggested that the
restriction site heterogeneity possibly occurred as a result of a
deletion of an approximately 3.6-kb region of the SXT element in
strains which were sensitive to SXT and streptomycin. Recent studies in
India have also shown that O139 strains are becoming increasingly
resistant to ampicillin and neomycin but increasingly susceptible to
chloramphenicol and streptomycin (20). Considering the
rapidly changing pattern of antibiotic resistance observed among
V. cholerae O139, it appears that there is substantial
mobility in other genetic elements encoding antimicrobial resistance in
V. cholerae O139.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of the SXT element in V. cholerae
O139 strains isolated between 1995 and 1998 in Bangladesh. Genomic DNA
was digested with BglI and probed with the SXT gene probe.
Lanes 1 through 5 show restriction patterns corresponding to SXT
genotype 1, whereas lanes 6 through 10 represent SXT genotype 2. Lane
numbers, place, and year of isolation of strains are as follows: 1 and
2, Matlab, 1995; 3 and 4, Dhaka, 1995; 5, Sunamganj, 1996; 6 and 7, Mymensingh, 1997; 8 and 9, Kishoreganj, 1997; 10, Bakerganj, 1998. Numbers indicating molecular sizes of bands correspond to a 1-kb DNA
ladder (BRL).
|
|
Origin of the new ribotype of V. cholerae O139.
Previous reports on the comparative analysis of V. cholerae
O139 and V. cholerae O1 suggested that strains belonging to
the O139 serogroup may have emerged from a genetic change in the
serotype-specific genes of a toxigenic El Tor strain. These studies
indicated that O139 strains resulted from the progenitor El Tor strain
due to insertion of a large foreign genomic region encoding
O139-specific genes and simultaneous deletion of most of the
O1-specific rfb gene cluster (5, 31). The donor
for the O139-specific DNA in this horizontal gene transfer event,
however, has not been identified. In agreement with previous reports, a
large region of chromosomal DNA representing the O1-specific
rfb gene cluster, including regions representing
rfbDEG, rfbNO, ompX,
orf2, and orf3, was found to be absent in all
O139 strains analyzed in the present study. PCR-based comparative
analysis of the O139 vibrios with specific primers corresponding to six
defined regions of the rfb gene cluster and flanking
sequences of V. cholerae O1 showed that while all six
regions could be amplified from control El Tor strains, the O139
strains showed positive amplification in two of the six PCR assays.
These two assays amplified a 497-bp region of the rfaD locus
and a 394-bp region corresponding to the rfbQRS locus in all
of the toxigenic O139 vibrios. All O139 strains were negative in the
PCR assays for chromosomal regions representing rfbDEG,
rfbNO, ompX, orf2, and orf3
of the rfb gene cluster of V. cholerae O1.
Southern hybridization analysis of genomic DNA with the O139-specific
probe also produced identical restriction patterns for all O139 vibrios
examined (data not shown). In addition, strains of the new ribotype
belonged to a ctxA genotype which was identical to that of
previously described O139 strains. Contrary to this, however, the
recently reemerged O139 strains in India have been reported to show an
altered organization of the CTX element (28).
The present study demonstrates the emergence of strains belonging to a
new ribotype which are otherwise identical to previously described
clones of O139 vibrios. Considering the ctxA genotypes, the
organization of the rfb genes, and the presence of other
virulence genes tested, it appears that the new ribotype probably did
not emerge from a recent gene transfer event comprising horizontal transfer of O139-specific genes from an unidentified donor; rather, it
seems more likely that the new ribotype originated from an existing
O139 strain. This agrees with a previous study by Ruiting and Reeves
(27) suggesting that recombination between rRNA operons can
give rise to ribotype diversity.
Epidemiological significance of ribotype diversity.
Previously
recorded events of appearance of new ribotypes of toxigenic V. cholerae in Bangladesh showed that the new ribotypes were also
distinct in their ctxA genotypes, suggesting that the new
ribotypes possibly emerged from nontoxigenic progenitors (7, 9). This would allow more phenotypic and genetic diversity among
toxigenic V. cholerae strains. The present study, on the other hand, shows that strains belonging to the new ribotype are otherwise genetically similar to previously described O139 strains. Hence, strains belonging to the new ribotype have epidemic or pandemic
potential similar to previously described O139 vibrios. However, the
new ribotype pattern of the strains has epidemiological application as
a marker in monitoring the spread of these pathogenic strains. In the
present study, all 19 strains isolated from the recent cholera outbreak
belonged to the new ribotype. This suggests that the recent outbreak in
northern Bangladesh probably started from a point source and coincided
with the origination of this new ribotype. Analysis of strains isolated
from other areas of Bangladesh during the same period showed that these
strains belong to previously described ribotypes, and hence the strains
associated with the outbreak were largely confined to the two
north-central districts of the country. During 1996, a new ribotype of
V. cholerae O139 was detected in Bangladesh and in the same
geographical region (9). However, in the present study we
did not find the presence of any strain belonging to this ribotype.
This suggests that in this region of Bangladesh the O139 vibrios are
undergoing rapid genetic reassortment, resulting in transient
appearance of different clones, whereas in the southern coastal region
the original ribotypes still exist as endemic strains. The reasons for
the rapid and transient emergence of different ribotypes of O139
vibrios in the northern region of Bangladesh are not clear.
Interplay of a variety of factors in the aquatic environment and
genetic and phenotypic changes in V. cholerae, as well as the immune status of the human host, may contribute to the existence and dominance of different clones of toxigenic V. cholerae.
We have previously reported different phenotypic and genetic changes in
V. cholerae O139 in Bangladesh and the prevalence of
different clones (1, 8). Although in the present study we
did not detect any change in the major pathogenic genes carried by the strains belonging to the new ribotype, we did not rule out the possibility of simultaneous genetic changes occurring in the rRNA operons and other unidentified genes that might influence the prevalence of the O139 strains by interacting with environmental factors. In view of the fluctuation observed in the prevalence of
V. cholerae O139 relative to that of V. cholerae
O1 in human infection (7, 9) and rapid genetic and
phenotypic changes, including changing patterns of antibiotic
resistance, further studies are required to explain the appearance and
disappearance of cholera epidemics and the mobility of genetic elements
encoding virulence properties as well as antimicrobial resistance.
 |
ACKNOWLEDGMENTS |
This research was funded by the U.S. National Institutes of
Health under grant RO1 AI39129-01A1 to the Department of International Health, Johns Hopkins University, and the ICDDR,B. The ICDDR,B is
supported by countries and agencies which share its concern for the
health problems of developing countries. Current donors providing core
support include the aid agencies of the governments of Australia,
Bangladesh, Belgium, Canada, China, Japan, Saudi Arabia, Sri Lanka,
Sweden, Switzerland, the United Kingdom, and the United States;
international organizations including the Arab Gulf Fund, the European
Union, the United Nations Children's Fund, the United Nations
Development Programme, and the World Health Organization; private
foundations including the Aga Khan Foundation, the Child Health
Foundation, the Ford Foundation, the Population Council, the
Rockefeller Foundation, the Thrasher Research Foundation, and the
George Mason Foundation; and private organizations including the East
West Center, Helen Keller International, the International Atomic
Energy Agency, the International Center for Research on Women, the
International Development Research Center, the International Life
Sciences Institute, Karolinska Institute, the London School of Hygiene
and Tropical Medicine, Lederle Praxis, the National Institute of
Health, New England Medical Center, Procter & Gamble, RAND Corporation,
the Social Development Center of Philippines, the Swiss Red Cross,
Johns Hopkins University, the University of Alabama at Birmingham, the
University of Iowa, the University of Goteborg, UCB Osmotics Ltd.,
Wander AG, and others.
We thank John Mekalanos, Harvard Medical School, Boston, Mass., for the
ToxR clone and the V. cholerae O139-specific probe and
Matthew Waldor, New England Medical Center, Boston, Mass., for the SXT clone.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Genetics Laboratory, Laboratory Sciences Division, ICDDR,B, GPO Box
128, Dhaka-1000, Bangladesh. Phone: 880 2 871751 to 880 2 871760. Fax: 880 2 872529 and 880 2 883116. E-mail: faruque{at}icddrb.org.
 |
REFERENCES |
| 1.
|
Albert, M. J.,
N. A. Bhuiyan,
K. A. Talukder,
A. S. G. Faruque,
S. Nahar,
S. M. Faruque,
M. Ansaruzzaman, and M. Rahman.
1997.
Phenotypic and genetic changes in Vibrio cholerae O139 Bengal.
J. Clin. Microbiol.
35:2588-2592[Abstract].
|
| 2.
|
Bauer, A. W.,
W. M. M. Kirby,
J. C. Sherris, and M. Turk.
1966.
Antibiotic susceptibility by a standardized single disk method.
Am. J. Clin. Pathol.
45:493-496[Medline].
|
| 3.
|
Brosius, J.,
A. Ullrich,
M. A. Raker,
A. Gray,
T. J. Dull,
R. R. Gutell, and H. F. Noller.
1981.
Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli.
Plasmid
6:112-118[Medline].
|
| 4.
|
Cholera Working Group, International Centre for Diarrhoeal Disease Research, Bangladesh.
1993.
Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal.
Lancet
342:387-390[Medline].
|
| 5.
|
Comstock, L. E.,
D. Maneval, Jr.,
P. Panigrahi,
A. Joseph,
M. M. Levine,
J. B. Kaper,
J. G. Morris, Jr., and J. A. Johnson.
1995.
The capsule and O-antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.
Infect. Immun.
63:317-323[Abstract].
|
| 6.
|
Everiss, K. D.,
K. J. Hughes,
M. E. Kovach, and K. M. Peterson.
1994.
The Vibrio cholerae acfB colonization determinant encodes an inner membrane protein that is related to a family of signal-transducing proteins.
Infect. Immun.
62:3289-3298[Abstract/Free Full Text].
|
| 7.
|
Faruque, S. M.,
K. M. Ahmed,
A. R. M. A. Alim,
F. Qadri,
A. K. Siddique, and M. J. Albert.
1997.
Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh.
J. Clin. Microbiol.
35:624-630[Abstract].
|
| 8.
|
Faruque, S. M.,
S. K. Roy,
A. R. M. A. Alim,
A. K. Siddique, and M. J. Albert.
1995.
Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns.
J. Clin. Microbiol.
33:2833-2838[Abstract].
|
| 9.
|
Faruque, S. M.,
K. M. Ahmed,
A. K. Siddique,
K. Zaman,
A. R. M. A. Alim, and M. J. Albert.
1997.
Molecular analysis of toxigenic Vibrio cholerae O139 Bengal strains isolated in Bangladesh between 1993 and 1996: evidence for the emergence of a new clone of the Bengal vibrios.
J. Clin. Microbiol.
35:2299-2306[Abstract].
|
| 10.
|
Faruque, S. M.,
Asadulghani,
A. R. M. Abdul Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139.
Infect. Immun.
66:3752-3757[Abstract/Free Full Text].
|
| 11.
|
Feinberg, A., and B. Volgelstein.
1984.
A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity.
Anal. Biochem.
137:266-267[Medline].
|
| 12.
|
Kaper, J. B.,
J. G. Morris, Jr., and M. Nishibuchi.
1988.
DNA probes for pathogenic Vibrio species, p. 65-77.
In
F. C. Tenover (ed.), DNA probes for infectious disease. CRC Press, Inc., Boca Raton, Fla.
|
| 13.
|
Karaolis, D. K.,
J. A. Johnson,
C. C. Bailey,
E. C. Boedeker,
J. B. Kaper, and P. R. Reeves.
1998.
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
Proc. Natl. Acad. Sci. USA
95:3134-3139[Abstract/Free Full Text].
|
| 14.
|
Keasler, S. P., and R. H. Hall.
1993.
Detection and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction.
Lancet
341:1661[Medline].
|
| 15.
|
Kovach, M. E.,
M. D. Shaffer, and K. M. Peterson.
1996.
A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae.
Microbiology
142:2165-2174[Abstract].
|
| 16.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 17.
|
Mekalanos, J. J.,
D. J. Swartz,
G. D. N. Pearson,
N. Harford,
F. Groyne, and M. Wilde.
1983.
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.
Nature
306:551-557[Medline].
|
| 18.
|
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475[Abstract/Free Full Text].
|
| 19.
|
Mitra, R.,
A. Basu,
D. Dutta,
G. B. Nair, and Y. Takeda.
1996.
Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India.
Lancet
348:1181[Medline].
|
| 20.
|
Mukhopadhyay, A. K.,
A. Basu,
P. Garg,
P. K. Bag,
A. Ghosh,
S. K. Bhattacharya,
Y. Takeda, and G. B. Nair.
1998.
Molecular epidemiology of reemergent Vibrio cholerae O139 Bengal in India.
J. Clin. Microbiol.
36:2149-2152[Abstract/Free Full Text].
|
| 21.
|
Nair, G. B.,
P. K. Bag,
T. Shimada,
T. Ramamurthy,
T. Takeda,
S. Yamamoto,
H. Kurazono, and Y. Takeda.
1995.
Evaluation of DNA probes for specific detection of Vibrio cholerae O139 Bengal.
J. Clin. Microbiol.
33:2186-2187[Abstract].
|
| 22.
|
Pearson, G. D. N.,
A. Woods,
S. L. Chiang, and J. J. Mekalanos.
1993.
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.
Proc. Natl. Acad. Sci. USA
90:3750-3754[Abstract/Free Full Text].
|
| 23.
|
Popovic, T.,
C. Bopp,
O. Olsvic, and K. Wachsmuth.
1993.
Epidemiological application of a standardized ribotype scheme for Vibrio cholerae O1.
J. Clin. Microbiol.
31:2474-2482[Abstract/Free Full Text].
|
| 24.
|
Popovic, T.,
P. I. Fields,
O. Olsvik,
J. G. Wells,
G. M. Evins,
D. N. Cameron,
J. J. Farmer III,
C. A. Bopp,
K. Wachsmuth,
R. B. Sack,
M. J. Albert,
G. B. Nair,
T. Shimada, and J. C. Feeley.
1995.
Molecular subtyping of toxigenic Vibrio cholerae O139 causing epidemic cholera in India and Bangladesh, 1992-1993.
J. Infect. Dis.
171:122-127[Medline].
|
| 25.
|
Ramamurthy, T.,
S. Garg,
R. Sharma,
S. K. Bhattacharya,
G. B. Nair,
T. Shimada,
T. Takeda,
T. Karasawa,
H. Kurazano,
A. Pal, and Y. Takeda.
1993.
Emergence of a novel strain of Vibrio cholerae with epidemic potential in Southern and Eastern India.
Lancet
341:703-704[Medline].
|
| 26.
|
Rivas, M.,
C. Toma,
E. Miliwebsky,
M. I. Caffer,
M. Galas,
P. Varela,
M. Tous,
A. M. Bru, and N. Binsztein.
1993.
Cholera isolates in relation to the "eighth pandemic."
Lancet
342:926-927[Medline].
|
| 27.
|
Ruiting, L., and P. R. Reeves.
1998.
Recombination between rRNA operons created most of the ribotype variation observed in the seventh pandemic clone of Vibrio cholerae.
Microbiology
144:1213-1221[Abstract].
|
| 28.
|
Sharma, C.,
S. Maiti,
A. K. Mukhopadhyay,
A. Basu,
I. Basu,
G. B. Nair,
R. Mukhopadhyaya,
B. Das,
S. Kar,
R. K. Ghosh, and A. Ghosh.
1997.
Unique organization of the CTX genetic element in Vibrio cholerae O139 strains which reemerged in Calcutta, India, in September 1996.
J. Clin. Microbiol.
35:3348-3350[Abstract].
|
| 28a.
| Siddique, A. K. Unpublished data.
|
| 29.
|
Siddique, A. K.,
K. Akram,
K. Zaman,
P. Mutsuddy,
A. Eusof, and R. B. Sack.
1996.
Vibrio cholerae O139: how great is the threat of a pandemic?
Trop. Med. Int. Health
1:393-398[Medline].
|
| 30.
|
Southern, E. M.
1975.
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
J. Mol. Biol.
98:503-517[Medline].
|
| 31.
|
Stroeher, U. H.,
K. E. Jedani,
B. K. Dredge,
R. Morona,
M. H. Brown,
L. E. Karageorgos,
M. J. Albert, and P. A. Manning.
1995.
Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139.
Proc. Natl. Acad. Sci. USA
92:10374-10378[Abstract/Free Full Text].
|
| 32.
|
Stull, T. L.,
J. J. LiPuma, and T. D. Edlind.
1988.
A broad spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.
J. Infect. Dis.
157:280-286[Medline].
|
| 33.
|
Taylor, R. K.,
V. L. Miller,
D. B. Furlong, and J. J. Mekalanos.
1987.
Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
Proc. Natl. Acad. Sci. USA
84:2833-2837[Abstract/Free Full Text].
|
| 34.
|
Waldor, M. K., and J. J. Mekalanos.
1996.
Lysogenic conversion by a filamentous phage encoding cholera toxin.
Science
272:1910-1914[Abstract].
|
| 35.
|
Waldor, M. K.,
H. Tschape, and J. J. Mekalanos.
1996.
A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
J. Bacteriol.
178:4157-4165[Abstract/Free Full Text].
|
| 36.
|
World Health Organization.
1974.
World Health Organization guidelines for the laboratory diagnosis of cholera.
Bacterial Disease Unit, World Health Organization, Geneva, Switzerland.
|
Journal of Clinical Microbiology, May 1999, p. 1313-1318, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.